Ingevity Corp 8-K

What Happened Ingevity Corporation (NGVT) filed an 8‑K on February 23, 2026, reporting that directors Jean S. Blackwell and Daniel F. Sansone will not stand for re‑election at the company’s 2026 Annual Meeting of Stockholders. Ms. Blackwell informed the Nominating & Governance Committee on February 17, 2026, and will remain a director until the 2026 Annual Meeting. Mr. Sansone’s decision follows the company’s retirement age policy. On February 17, 2026, the Board approved reducing its size to nine directors effective as of the 2026 Annual Meeting.

Key Details

• Jean S. Blackwell informed the Nominating & Governance Committee on February 17, 2026, that she will not stand for re‑election; she said her decision was not due to any disagreement with the company.
• Daniel F. Sansone will not stand for re‑election in accordance with Ingevity’s retirement age policy.
• The Board approved decreasing its size to nine directors, effective as of the 2026 Annual Meeting.
• A press release announcing these board changes is attached as Exhibit 99.1 to the 8‑K.

Why It Matters Board departures and a reduction in board size affect corporate governance and who will oversee strategy, risk and executive oversight. The filing does not disclose any operational or financial impact; these are governance changes and appear to reflect routine retirement and voluntary departures. Investors should watch Ingevity’s proxy materials and announcements leading up to the 2026 Annual Meeting for information on new nominees, committee assignments, and any broader governance changes.